Antimicrobial Silver Fights Wound Infection

By HospiMedica staff writers
Posted on 02 Jul 2002
A new dressing for wounds features controlled-release antimicrobial silver, designed to fight antibiotic-resistant bacteria, especially in deep, hard-to-treat wounds.

Called Arglaes, the new dressing has no known resistance or major side effects and maintains an effective antimicrobial barrier for up to five days. Utilizing controlled-release polymers, Arglaes delivers a constant stream of silver ions into the wound either in a film or powder form. In addition, the powder form contains alginate to aid in fluid handling. As the powder mixes with wound fluid, it turns into a gel that adheres to the wound bed and is easily removed during wound irrigation. Arglaes is appropriate for use on trauma injuries, incisions, minor burns, dermal lesions, and arterial, venous, and diabetic ulcers. The dressing was developed by Maersk Medical, Inc. (Lynge, Denmark).

"Arglaes appears to have a significant advantage in reducing the incidence of infection,” said Stephen B. Colvin, M.D., chief of cardiothoracic surgery at New York University School of Medicine (NY, USA). Dr. Colvin had conducted clinical and scientific studies using Arglaes and is now using it as part of his post-surgical protocol.




Related Links:
Maersk Medical, Inc.

Latest Surgical Techniques News